OCP/DARS IDIQ 5 year purchase of cells

This contract entails a five-year indefinite delivery, indefinite quantity (IDIQ) agreement focused on the purchase of cells intended for research on microphysiological systems. It is issued by the Food and Drug Administration under the NAICS code 541714, which relates to research and development in biotechnology. The primary objective is to secure a reliable supply of cells that will support ongoing and future studies, crucial for advancing understanding and innovation in biomedical research. The contract is currently in a forecast stage as of March 2026, with key points of contact outlined for acquisition and contracting, although the specific contracting officer has yet to be assigned. While the solicitation number and precise location details are not provided, the arrangement is designed to facilitate multiple orders over the contract duration to meet the FDA's recurring needs in this specialized area. This demonstrates the agency's commitment to fostering long-term partnerships that ensure consistent quality and availability of critical biological materials necessary for cutting-edge scientific investigations.